This established private optometry practice has served the Houston community since 2004 and has operated from the same location for approximately 22 years with a strong 4.6 ★ Google reputation based on 38 reviews and a 4.4 ★ Yelp reputation based on 26 reviews. The practice generated approximately $644,000 in 2023, $620,000 in 2024, and $609,000 in 2025, demonstrating consistent annual production above $600,000. The completed valuation supports a normalized owner benefit of approximately $165,000–$195,000 annually, with a selected normalized owner benefit of approximately $180,000.
The practice reports approximately 2,078 active patients seen within the last two years, more than 15,300 total patient records, approximately 1,200 annual patient visits, and roughly 175 new patients per year. The office is typically booked approximately two weeks in advance and uses examWRITER / OfficeMate for EHR and practice management, with monthly postcards and Weave supporting patient recall and communication. The submitted growth report separately shows 1,655 fee-slip-based patient encounters in 2025, including 196 new-patient encounters, so those figures should not be treated as directly interchangeable with the seller’s annual-visit estimates.
The practice provides a broad scope of care including comprehensive primary eye care, medical eye care, LASIK/PRK/cataract co-management, and optical sales. The established optical dispensary, medical-care capabilities, co-management relationships, and relatively high revenue per patient provide a strong foundation for an incoming owner. No projected revenue from additional specialty services has been incorporated into the normalized earnings analysis.
The practice participates with a diverse group of vision plans including VSP, EyeMed, Davis Vision, Superior Vision, NVA, and Guardian Vision. Medical panels include Medicare, Blue Cross Blue Shield, UnitedHealthcare, Aetna, Cigna, and Humana, providing an established payer infrastructure for both routine and medical eye care.
The owner currently works approximately four clinical days per week and plans to retire following the sale. The practice previously utilized an associate OD approximately one day per week, although that associate was scheduled to discontinue in mid-September 2026. No associate-pay savings have been incorporated into the normalized owner benefit because the buyer’s future clinical coverage, associated costs, and revenue retention remain to be determined. The seller is willing to remain for approximately three to six months after closing to support a smooth ownership transition.
The practice has two full-time staff members, including an Office Manager with approximately 15 years of tenurewho manages optical operations, lens edging, billing, staff management, and administration. The Optician / Receptionist has approximately three years of tenure and supports optical sales, recall, inventory, ordering, insurance verification, and reception. There are no employment contracts or non-compete agreements currently in place, and no staff-reduction savings have been incorporated into the valuation.
The approximately 1,200-square-foot office includes one fully equipped exam lane and operates Tuesday through Saturday, with weekday hours of approximately 8:30 AM–5:00 PM and Saturday hours of 9:00 AM–2:00 PM. The seller reports current total monthly occupancy of approximately $5,725, while the signed lease amendment shows scheduled base rent of approximately $4,233 per month through October 2026, increasing to approximately $4,338 per month beginning November 2026, with additional occupancy charges separate. The current term expires October 31, 2027, and the signed sixth amendment does not provide an additional renewal option, making acceptable future lease terms an important transaction condition.
The practice includes a substantial technology and equipment platform. Major equipment includes a Cirrus 6000 OCT, Zeiss retinal camera, autorefractor, slit lamp, optical edger, phoropter, exam chair and stand, optical lab equipment, and extensive office technology. Equipment with seller-stated values totals approximately $77,000, although several additional operating assets do not have assigned values and therefore are not included in that figure. The valuation treats the Cirrus 6000 OCT at a seller-stated value of approximately $65,000, subject to final confirmation of ownership and prior lease termination.
The completed valuation identifies approximately $44,375 in total inventory, consisting of approximately $33,573 in frames, $8,302 in contact lens stock, and $2,500 in single-vision lens stock. Final inventory should be physically counted and reconciled to documented cost prior to closing, with expired, damaged, third-party-owned, or otherwise unsaleable merchandise excluded.
The seller reports no practice loans or liens. The leased visual-field equipment remains a separate obligation requiring review, while current accounts receivable are approximately $15,000 and are excluded unless separately negotiated. The valuation assumes an asset purchase in which seller debts remain with the seller unless specifically assumed by the buyer.
Growth opportunities remain attractive because the practice has limited current marketing activity and an established patient base with strong online reviews. A buyer could expand digital marketing, social media, reputation management, recall outreach, optical conversion, and referral development while further utilizing the practice’s medical eye-care capabilities. Additional specialty services may also provide upside, but no speculative revenue from advertising, specialty services, or operational improvements has been included in normalized earnings or debt-service calculations.
This opportunity is particularly well suited for a hands-on owner-operator seeking an established Houston practice with $600,000+ in consistent annual revenue, approximately $180,000 in normalized owner benefit, 2,000+ active patients, experienced long-term staff, broad insurance participation, a strong optical operation, advanced diagnostic technology, and seller transition support. The combination of durable historical production, established patient relationships, and identifiable growth opportunities provides an attractive platform for both immediate ownership income and future expansion.
100% Bank Financing Available for qualified buyers through conventional lenders.
For more information, including a comprehensive practice appraisal report and detailed financial package, please complete our Buyer Registration Form and Confidentiality Agreement.
